These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1818767)

  • 1. The pharmacokinetics and distribution of pamidronate for a range of doses in the mouse.
    Hoggarth CR; Bennett R; Daley-Yates PT
    Calcif Tissue Int; 1991 Dec; 49(6):416-20. PubMed ID: 1818767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disposition and nephrotoxicity of 3-amino-1-hydroxypropylidene-1,1-bisphosphonate (APD), in rats and mice.
    Cal JC; Daley-Yates PT
    Toxicology; 1990 Dec; 65(1-2):179-97. PubMed ID: 1980383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of the pharmacokinetics of 14C-labelled APD and 99mTc-labelled APD in the mouse.
    Daley-Yates PT; Bennett R
    Calcif Tissue Int; 1988 Aug; 43(2):125-7. PubMed ID: 3142665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clearance and tissue uptake following 4-hour and 24-hour infusions of pamidronate in rats.
    Pongchaidecha M; Daley-Yates PT
    Drug Metab Dispos; 1993; 21(1):100-4. PubMed ID: 8095201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biodistribution studies of the 186Re complex of 3-amino-1-hydroxypropylidene-1,1-bisphosphonic acid in mice.
    Alyafei S; Tomiyoshi K; Sarwar M; Ahmed K; Zhang H; Oriuchi N; Inoue T; Endo K
    Nucl Med Commun; 1999 Jun; 20(6):551-7. PubMed ID: 10451868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of the osteotropic diphosphonate 3-amino-1-hydroxypropane-1,1-diphosphonic acid in mammals.
    Wingen F; Schmähl D
    Arzneimittelforschung; 1987 Sep; 37(9):1037-42. PubMed ID: 3435598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of pretreatment with 3-amino-1-hydroxypropylidene-1,1-bisphosphonate (APB) on organ uptake of 211At and 125I-labeled amidobisphosphonates in mice.
    Murud KM; Larsen RH; Bruland OS; Hoff P
    Nucl Med Biol; 1999 Oct; 26(7):791-4. PubMed ID: 10628558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomechanical effects of the full range of useful doses of (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD) on femur diaphyses and cortical bone tissue in rats.
    Ferretti JL; Cointry G; Capozza R; Montuori E; Roldán E; Pérez Lloret A
    Bone Miner; 1990 Oct; 11(1):111-22. PubMed ID: 2268736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apposition and resorption of bone during oral treatment with (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD).
    Reitsma PH; Bijvoet OL; Potokar M; van der Wee-Pals LJ; van Wijk-van Lennep MM
    Calcif Tissue Int; 1983 May; 35(3):357-61. PubMed ID: 6871766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is (99m)Tc-labelled pamidronate a better agent than (99m)Tc-medronate for bone imaging?
    Kumar V; Kumar D; Howman-Giles RB; Little DG
    Nucl Med Commun; 2007 Feb; 28(2):101-7. PubMed ID: 17198350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preliminary study of multiple increasing oral doses of dimethyl-APD on bone metabolism dynamics and safety profile.
    Vega E; Mautalen C; Roldán EJ; Pérez Lloret A
    Drugs Exp Clin Res; 1994; 20(3):103-8. PubMed ID: 7956716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pamidronate content and turnover in sternum, vertebral body, and iliac bones of dogs.
    King LE; Grynpas MD; Tomlinson G; Vieth R
    Bone; 1997 May; 20(5):405-11. PubMed ID: 9145237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of incadronate, a new bisphosphonate, in healthy volunteers and patients with malignancy-associated hypercalcemia.
    Usui T; Oiso Y; Tomita A; Ogata E; Uchida T; Ikeda K; Watanabe T; Higuchi S
    Int J Clin Pharmacol Ther; 1997 Jun; 35(6):239-44. PubMed ID: 9208339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of pamidronate in patients with bone metastases.
    Leyvraz S; Hess U; Flesch G; Bauer J; Hauffe S; Ford JM; Burckhardt P
    J Natl Cancer Inst; 1992 May; 84(10):788-92. PubMed ID: 1573666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential action of the bisphosphonates (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD) and disodium dichloromethylidene bisphosphonate (Cl2MDP) on rat macrophage-mediated bone resorption in vitro.
    Reitsma PH; Teitelbaum SL; Bijvoet OL; Kahn AJ
    J Clin Invest; 1982 Nov; 70(5):927-33. PubMed ID: 7130396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pamidronate distribution in pediatric renal and rheumatologic patients.
    Acott PD; Wong JA; Crocker JF; Lang B; O'Regan P; Renton KW
    Eur J Clin Pharmacol; 2006 Dec; 62(12):1013-9. PubMed ID: 17024486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytotoxic effects of pamidronate on monolayers of human intestinal epithelial (Caco-2) cells and its epithelial transport.
    Twiss IM; de Water R; den Hartigh J; Sparidans R; Ramp-Koopmanschap W; Brill H; Wijdeveld M; Vermeij P
    J Pharm Sci; 1994 May; 83(5):699-703. PubMed ID: 8071824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of single and multiple intravenous infusions of 3-amino-1-hydroxypropylidene-1, 1-bisphosphonate (APD) in the treatment of hypercalcemia of malignancy.
    Yates AJ; Murray RM; Jerums GJ; Martin TJ
    Aust N Z J Med; 1987 Aug; 17(4):387-91. PubMed ID: 3435316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteoclast recruitment in mice is stimulated by (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate.
    Marshall MJ; Holt I; Davie MW
    Calcif Tissue Int; 1993 Jan; 52(1):21-5. PubMed ID: 8453501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maintained improvement in calcium balance and bone mineral content in patients with osteoporosis treated with the bisphosphonate APD.
    Valkema R; Vismans FJ; Papapoulos SE; Pauwels EK; Bijvoet OL
    Bone Miner; 1989 Jan; 5(2):183-92. PubMed ID: 2920240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.